mRNA Based SARS-CoV-2 Vaccine Candidate CVnCoV Induces High Levels of Virus Neutralizing Antibodies and Mediates Protection in Rodents
Susanne Rauch et.al., bioRxiv (2020) - PMID: n.a.
Product(s) used in this publication: PepMix™ Peptide Pools
Abstract
n.a.